Neisvac C Baxter

NeisVac-C® Vaccine

All Rights Reserved ® NeisVac-C is a trademark of Baxter International Inc., used under license by GlaxoSmithKline Inc. Last revised: January 21, 2009

gsk.ca

NeisVac-C Vaccine

Name and address of the sponsor NeisVac-C vaccine is manufactured by: BioScience Division Baxter Healthcare Corporation Beltsville, Maryland, USA. Distributed in Australia by: Baxter Healthcare Pty Ltd ABN 43 000 392 781 1 Baxter Drive Toongabbie NSW 2146, Sydney The last CMI revision: March 2006

www.mydr.com.au

Products & Services Directory

Baxter provides vaccines for meningitis C, tick-borne encephalitis, and ... NEISVAC-C† VACCINE

www.baxter.com

SUMMARY OF PRODUCT CHARACTERISTICS

Booster doses It is recommended that a booster dose should be given after completion of the primary immunisation series in infants. The timing of this dose should be in accordance with 1 NeisVac-C is a trademark of Baxter International Inc.

www.immunisation.ie

Patient Group Direction for the administration of ...

NeisVac-C ® (Baxter Healthcare Ltd) is a suspension for injection in a 0.5mL pre-filled syringe. The vaccine should be well shaken before use in order to obtain a homogenous suspension.

www.nhsgrampian.com

Report of the Committee on Safety of Medicines Expert Working ...

Subsequently immunisation with Meningitis C vaccines became part of the routine infant immunisation programme, being given at ages two, three and four months. 1.2 Licensing of Meningitis C Vaccines Three vaccines were used in the campaign : Meningitec (Wyeth), Menjugate (Chiron) and Neisvac-C (Baxter).

www.mhra.gov.uk

Interim guidelines for immunisation providers

These interim recommendations relate only to the Meningococcal C conjugate vaccines (MenCCV), specifically Meningitec (Wyeth), Menjugate (CSL Vaccines/Chiron) and NeisVac-C (Baxter Healthcare).

www.nevdgp.org.au

Patient Group Direction for administration of X medication

NeisVac-C® (Baxter) Summary of Product Characteristics last updated: 21/01/2009 http://www.gsk.ca/english/docs-pdf/NeisVacC_PM_20090121_EN. pdf

www.leeds.nhs.uk

Carbohydrate Based Vaccines

Neisseriameningitidis Capsular Neisseriameningitidis Capsular Polysaccharide-Conjugate Vaccine Polysaccharide-Conjugate Vaccine Meningitec® : Wyeth Meningitec®: Wyeth Menjugate® : Chiron Menjugate®: Chiron NeisVac NeisVac-C®-C®: Baxter Protein-CPS conjugate vaccines are currently Protein-CPS ...

www.ccrc.uga.edu

Meningococcal disease - Fact sheet - NCIRS - PDF

Meningococcal C conjugate vaccines 5 Meningitec - Wyeth Australia Pty Ltd: meningococcal serogroup C-CRM 197 conjugate vaccine Menjugate syringe - CSL Biotherapies/Novartis Vaccines and Diagnostics: meningococcal serogroup C-CRM 197 conjugate vaccine NeisVac-C - Baxter Healthcare: meningococcal serogroup C ...

www.ncirs.edu.au

Other sites you could try:

Find videos related to Neisvac C Baxter